PDF Cover

Anesthesia And Respiratory Devices Market

The market for Anesthesia And Respiratory Devices was estimated at $58.9 billion in 2024; it is anticipated to increase to $84.5 billion by 2030, with projections indicating growth to around $114 billion by 2035.

Report ID:DS1801096
Author:Debadatta Patel - Senior Consultant
Published Date:
Datatree
Life Science
Medical Device
Anesthesia And Respiratory Devices
Share
Report Summary
Market Data
Methodology
Table of Contents

Global Anesthesia And Respiratory Devices Market Outlook

Revenue, 2024

$58.9B

Forecast, 2034

$107B

CAGR, 2025 - 2034

6.2%

The Anesthesia And Respiratory Devices industry revenue is expected to be around $62.5 billion in 2025 and expected to showcase growth with 6.2% CAGR between 2025 and 2034. The proposed expansion of Anesthesia And Respiratory Devices market activity highlights the significance of this industry for the health service sector, particularly as health authorities become increasingly keen on ensuring that patients receive the best possible care before, during and after surgery. The increasing number of surgical procedures being performed, combined with the increasing prevalence of respiratory conditions, are driving the demand for advanced respiratory care equipment. The Anesthesia and Respiratory Devices sectors Respiratory Devices product region generated a significant amount of sales in the year 2024, totalling $36.81 billion. It dominated the sector with its substantial revenue. Demand is driven primarily by the clinical region's of acute care and critical care as well as chronic respiratory diseases which account for 63 % of the demand for ventilators. Continuous advances in monitoring technology, automation and connectivity are leading healthcare providers to replace outdated equipment with integrated systems which can improve clinical care and the efficiency of services Anesthesia equipment and respiratory devices range from ventilators to nebulisers, and from anaesthetic machines to oxygen therapy apparatus, all of which are designed to deliver precise anesthetic administration and ventilatory support. The products in this group cover a wide range of equipment including nebulizers, anesthetic machines, ventilators and oxygen therapy apparatus.

These devices are designed to give precise anesthetic administration and ventilatory support. These devices are central to modern intensive care units, emergency departments and operating rooms due to advanced flow controls, real time patient monitoring, ergonomically designed interface systems and integration with electronic healthcare information. The key uses of this technology are in intensive care, chronic respiratory diseases, in the recovery room, and in anaesthesia. There is also a growing use in out patient clinics and in peoples own homes. The demand for respiratory devices is being driven by several factors, including growing use of non invasive ventilation technology. Furthermore, there is a trend towards less invasive treatments which are often performed on an outpatient basis. There is also a development of portable and home use friendly respiratory devices. Additionally, the use of information technology in health care to monitor patients from a distance and to improve the management of respiratory and anaesthesia services is also on the increase.

Anesthesia And Respiratory Devices market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2024-2034
Anesthesia And Respiratory Devices Market Outlook

Market Key Insights

  • The Anesthesia And Respiratory Devices market is projected to grow from $58.9 billion in 2024 to $107 billion in 2034. This represents a CAGR of 6.2%, reflecting rising demand across Perioperative Care, Chronic Respiratory Diseases, and Acute Care & Critical Care.

  • Among the leading figures in this industry are Acutronic Medical Systems AG, Alung Technologies Inc and Airsep Corp. They define the current competitive environment.

  • The US and Germany are the two most significant markets in the global industry for anaesthesia and respiratory devices, with a projected growth rate between 4 and 6% by the years 2030.

  • The fastest growth rates are expected to be experienced in emerging markets such as South Africa, India and Brazil, with a Compound Annual Growth Rate of 7.1 8.6% .

  • The impact of digital transformation on the value chain in the United States and Germany for respiratory and anaesthesia equipment is significant. By 2030 it could add three billion U. S dollars to theindustry'srevenue.

  • Between 2024 and 2034, it is predicted that the Anesthesia & Respiratory Devices industry will experience a growth of $48.6 billion. A greater market share in the Anesthesia and Respiratory Devices industry will be gained by those manufacturers targeting chronic respiratory diseases and the perioperative care region.

  • With

    rising prevalence of chronic respiratory diseases and growing geriatric population, and

    Technological Advancements in Smart, Connected Respiratory Devices and Remote Monitoring, Anesthesia And Respiratory Devices market to expand 82% between 2024 and 2034.

anesthesia and respiratory devices market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032
Anesthesia And Respiratory Devices - Country Share Analysis

Opportunities in the Anesthesia And Respiratory Devices

Europe is also at present suffering severe staffing shortages in both intensive care units and in the doctors and nurses who staff them, this in turn may lead to more hospitals using computer based intensive care technology. High end ventilators and patient monitoring equipment are being fitted with complex algorithms that help nurses and doctors implement lung protective ventilation strategies and automatically adjust the ventilation level for patients who are recovering. Healthcare organisations are seeking suppliers who can readily interface with tele ICU command centres and electronic health records. By 2030 Europe is predicted to be the market leader in terms of the growth rate for high acuity respiratory care products used in intensive care. Global revenues for respiratory products are expected to reach $54.31 billion.

Growth Opportunities in North America and Asia-Pacific

Chronic respiratory disorders drive the demand for respiratory care devices in North America, which has high prevalence rates of conditions such as asthma, chronic obstructive pulmonary disease and sleep apnea. This drives demand for home ventilation equipment and other respiratory care products. Key factors that drive demand include strict clinical guidelines, high levels of use of intensive care facilities and strong reimbursements for chronic disease treatment. These factors benefit premium non invasive ventilators, high velocity nasal cannula therapy and connected spirometry equipment. This equipment is linked to digital health systems. With competition being driven by strong hospital purchasing groups and advanced medical equipment, suppliers are therefore required to have strong data analytics capabilities, smart monitoring and also interoperability across their medical devices such as ventilators and anaesthesia machines. Significant business opportunities exist in expanding remote monitoring services for the treatment of chronic respiratory disease, also expanding home care respiratory therapy services and repositioning anaesthesia delivery machines for ambulatory surgical centres and for out patient surgical care. This will be supported by subscription based business models which are driven by services and by decision making tools which are integrated with clinical practice.
Asia Pacific is the largest market for acute care and critical care equipment for anaesthesia and respiration, with the demand for intensive care equipment driven by the expanding hospital infrastructure and increased ICU facilities. There are a number of factors driving the market in this region. These include a growing number of surgical procedures being performed, a greater awareness of the importance of care given before, during and after surgery and the need to reduce the high incidence of respiratory diseases. In the medical industry, companies manufacturing medical devices are under pressure from low cost regional manufacturers. This pressure is further intensified by the innovative companies operating at a global level. Three of the key elements which are crucial for success are competitive pricing, after sales services and product customisation as per the market. These factors are especially vital in cases of public procurement contracts and large private hospital chains. The business can be developed in the mid tier, value engineered anaesthetic workstations, portable non invasive ventilation and high flow nasal cannula therapy for secondary and the tertiary cities. It can also be done in the peri operative monitoring systems in the varied resource settings.

Market Dynamics and Supply Chain

01

Driver: Rising Prevalence of Chronic Respiratory Diseases and Growing Geriatric Population

The anesthesia and respiratory devices market is also strongly driven by the increasing prevalence of chronic respiratory diseases such as COPD, asthma, and sleep apnea, alongside the global rise in aging populations. Chronic respiratory conditions require long-term management with devices like ventilators, oxygen concentrators, and nebulizers, driving hospital and homecare adoption. Aging populations are also more susceptible to respiratory complications, increasing demand for advanced anesthesia and respiratory support devices. Together, these factors accelerate device utilization in hospitals, pulmonary clinics, and homecare settings, boosting overall market growth. Innovations in portable oxygen delivery, compact ventilators, and user-friendly homecare devices also enhance patient adherence and outcomes, making these solutions essential in chronic disease management and reinforcing investment in R&D and infrastructure by leading players.
A key driver is also the integration of smart technology and remote monitoring in anesthesia and respiratory devices. Connected ventilators, oxygen concentrators, and CPAP machines allow real-time patient monitoring, data analytics, and telehealth support, improving clinical outcomes and enabling proactive care. Hospitals and homecare providers increasingly adopt these technologies to optimize therapy, reduce hospital readmissions, and enhance patient compliance. This trend toward digital and IoT-enabled respiratory solutions is also expanding market opportunities across developed and emerging regions, making device innovation a core growth strategy. 
02

Restraint: High Cost of Devices

Investing in anesthesia and respiratory equipment is an expense for healthcare institutions as they grapple with the challenge of managing budgets while aiming to provide top notch patient care – a factor that can hinder market expansion efforts. Regrettably the initial investment required often makes these critical tools inaccessible, to smaller healthcare providers and developing nations alike ultimately affecting the pace of market growth.
03

Opportunity: Rising demand for low-flow anesthesia delivery systems in cost-constrained public hospitals across Latin America and Expanding adoption of home-care respiratory devices for elderly COPD patients in rapidly urbanizing Asian megacities

There has been a rise in the number of elective operations in Mexico, Brazil, Colombia and Chile, yet those hospitals run by the state remain financially strained. This trend is beneficial to anaesthetists who prefer low flow anaesthetic machines, compact vaporizers and monitoring accessories which reduce consumption of anaesthetic agents and the costs of ownership over the lifetime of the equipment. Local partnerships with manufacturers and distributors could be used to cater to secondary cities and ambulatory surgery centres which have limited access to healthcare services. Latin America public sector operating room medical device sales should grow faster than the market as a whole for low cost anaesthetic equipment. The market as a whole for anaesthetic equipment should be worth $30.17 billion in the year 2030. It is expected that this anaesthetic equipment market will have a compound annual growth rate of 5.34%.
The rapid growth of cities in Asia is bringing about a marked increase in the numbers of people suffering from asthma and chronic obstructive pulmonary disease. As a result hospitals are coming under a lot of strain. The growing interest in the treatment of sleep and respiratory disorders is boosting demand for portable home use devices. region's with elderly populations which are located in districts at the edge of towns continue to be poorly served in terms of healthcare access. This is particularly the case in region's where the government is only just starting to pay for healthcare by telephone. The Asia Pacific market for respiratory equipment used at home will grow faster than the total respiratory equipment market which is expected to expand from $36.81 billion in 2024 to $54.31 billion by 2030 at a growth rate of 6.7%.
04

Challenge: Stringent Regulatory Policies

Before anesthesia and respiratory devices can be sold to the market for use in medical procedures like surgeries or treatments they must pass through strict regulations and approval procedures to ensure safety standards are met and potential risks are minimized in case of device failure during operation or treatment sessions Despite the importance of this scrutiny it can sometimes cause delays in getting these vital medical devices out to those who need them due, to the detailed nature of the approval process their release can be slowed down causing frustration among those awaiting their availability

Supply Chain Landscape

1

Component Sourcing

Amsino International IncBomimed Inc
2

Anesthesia Respiratory Devices

Acutronic Medical Systems AgAirsep CorpAlung Technologies Inc
3

Distribution Services

Bomimed IncAmsino International Inc
4

Clinical End Users

HospitalsAmbulatory Surgical CentersHomecare Settings
Anesthesia And Respiratory Devices - Supply Chain

Use Cases of Anesthesia And Respiratory Devices in Perioperative Care & Acute Care & Critical Care

Perioperative Care : Perioperative care in the anesthesia and respiratory devices market involves critical support before, during, and after surgery using devices such as anesthesia delivery machines, ventilators, breathing circuits, airway management tools, and respiratory masks to maintain patient ventilation and gas exchange in operating rooms and recovery units. Hospitals and surgical centers rely on integrated anesthesia workstations and monitoring systems from GE HealthCare, Medtronic, Drägerwerk, Teleflex, and Philips Healthcare, which are noted for reliability, advanced safety features, and global service networks that enhance perioperative patient outcomes.
Chronic Respiratory Diseases : Respiratory support is essential in managing chronic respiratory diseases such as COPD and severe asthma, where anesthesia and respiratory devices like nebulizers, oxygen concentrators, ventilators, and inhalers are widely used by hospitals, pulmonary clinics, and homecare settings to improve breathing and quality of life. Nebulizers convert medications into fine aerosols for deep lung delivery, while portable oxygen systems and advanced ventilators support long‑term oxygen therapy and respiratory function. Leading players such as Philips Healthcare, ResMed Inc., Medtronic, Fisher & Paykel Healthcare, and Drägerwerk AG provide high‑performance, patient‑centric devices integrated with smart monitoring and remote care features, strengthening their positions in chronic respiratory care globally.
Acute Care & Critical Care : Acute care and critical care heavily rely on anesthesia and respiratory devices such as advanced anesthesia workstations, mechanical ventilators, and airway management systems to support patients undergoing surgery and those with respiratory failure in ICUs and emergency units. These devices enable precise delivery of anesthetic gases, real‑time monitoring of vital signs, and effective ventilatory support for acute respiratory distress. Hospitals and critical care centers favor integrated solutions from leaders like GE Healthcare, Medtronic, Philips Healthcare, and Drägerwerk AG & Co. KGaAP for their reliability, connectivity, and safety features that enhance clinical outcomes in high‑acuity settings.

Recent Developments

Recent developments in the anesthesia and respiratory devices industry reflect strong momentum in connected care, AI‑driven monitoring, and advanced ventilator technologies, driven by rising chronic respiratory disease prevalence and surgical demand. Manufacturers are prioritizing smart ventilators and portable respiratory systems, such as connected CPAP updates with real‑time remote monitoring and adaptive pressure control that enhance treatment adherence and patient engagement. Integration of IoT and digital health capabilities is a key trend, enabling remote therapy management, data sharing with clinicians, and improved clinical outcomes across hospital and home care settings.

May 2025 : AirSep Corp introduced its N2WAVE™ Twin Tower and Modular Series PSA nitrogen gas generators, expanding its gas generation product line with advanced pressure swing adsorption technology that delivers high‑purity nitrogen for diverse industrial and medical applications. This move enhances AirSep’s equipment portfolio and supports broader clinical and facility needs where reliable gas supply infrastructure is critical. 
November 2024 : Amsino International completed the acquisition of MedXL Inc., significantly increasing its manufacturing footprint and production capacity, particularly for prefilled and related therapy products, thereby strengthening supply chain resilience and market reach in infusion and respiratory support products.
April 2025 : Amsino International, Inc. announced the establishment of Amsino Scientific Inc. in Franklin, Massachusetts, a new manufacturing, research, and development facility aimed at accelerating production capacity and innovation in medical device technologies, enhancing its role in the anesthesia and respiratory supply chain.

Impact of Industry Transitions on the Anesthesia And Respiratory Devices Market

As a core segment of the Medical Device industry, the Anesthesia And Respiratory Devices market develops in line with broader industry shifts. Over recent years, transitions such as Digital Transformation in Anesthesia and Respiratory Devices and Shift from Conventional to Portable Respiratory Devices have redefined priorities across the Medical Device sector, influencing how the Anesthesia And Respiratory Devices market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Digital Transformation in Anesthesia and Respiratory Devices

The Anesthesia And Respiratory Devices industry is set to be driven by digital transformation, which is introducing ML and AI into product development and business processes. This is notably the case in both Germany and the US. With the development of advanced equipment such as intelligent ventilators and anaesthetic machines using AI, operating theatres are now better able to provide respiratory care and monitor patients more effectively. This is resulting in better care for patients and increased efficiency in hospitals. By 2030, smart, interconnected anaesthesia devices and digital health integration could create roughly $3 billion in extra income for the industry as operating theatres and hospitals increasingly adopt systems which work with one another. This leads to competitive advantage being increasingly determined by the ability to integrate advanced analytics and automation into critical care solutions, in turn this drives both higher utilisation rates and premium pricing across key markets.
02

Shift from Conventional to Portable Respiratory Devices

The anesthesia and respiratory devices industry is transitioning from traditional, bulky hospital-based ventilators and oxygen systems to portable and home-use respiratory devices. Compact ventilators, lightweight oxygen concentrators, and handheld nebulizers enable patients with chronic respiratory diseases to receive therapy outside hospital settings, enhancing mobility and quality of life. This shift has impacted the home healthcare and telemedicine sectors, increasing demand for connected monitoring solutions, remote patient management platforms, and device rental services. Manufacturers are investing in miniaturization, battery efficiency, and smart integration to support outpatient care, reducing hospital stays and reshaping the respiratory device supply chain toward patient-centric delivery models.